NGVT

Analyst Note: Ingevity Corporation (NGVT)

Date: 2026-06-13 Ticker: NGVT Sector: Materials Industry: Specialty Chemicals / Activated Carbon

1. Structural Readiness

Conservative Entry: $64.44 Current Price: $73.41 Extension: +13.9% vs. conservative entry Breakout Level: $64.44 (Conservative Entry)

2. Thesis Layer

As of 2026-06-13, there is no named secular thesis attached to this setup. This is a TACTICAL, setup-led name. The conviction must be derived strictly from the quality of the technical structure (the confirmed coil breakout) and the immediate business fundamentals disclosed by management. We do not invent a macro thesis; we judge the setup on its own merits: a confirmed breakout supported by strong earnings guidance and a clear strategic simplification narrative.

3. Business Overview

Ingevity Corporation is a global provider of advanced chemical solutions and activated carbon products. The company operates through two primary reportable segments: Performance Materials and Performance Chemicals.

• Performance Materials: This segment focuses on the engineering, manufacturing, and sale of chemically activated carbon products, primarily derived from hardwood. These products are critical for automotive gasoline vapor emissions control systems, as well as purification applications in food, water, beverages, and industrial chemicals.
• *Evidence:* Management noted that Performance Materials delivered growth in net sales, segment EBITDA, and margin, driven by price increases and a shift in consumer preference from battery electric vehicles (BEVs) toward hybrids, which utilize more advanced carbon solutions (E5, E7, E14).
• *Financials:* Net sales for this segment in 2025 were $606.9 million (E19). For 2026, the company expects net sales in this segment to grow low-single digits, with increased pricing partially offsetting a forecasted decline in global automotive production for ICE powertrains (E12).

• Performance Chemicals: This segment covers pavement technologies, industrial specialty products, and engineered polymers. It includes warm mix asphalt products, additives for oil well services, and components for adhesives, agrochemicals, and bioplastics.
• *Evidence:* Excluding the divested road markings product line (completed April 15, 2026), the company expects net sales in this segment to grow mid-single digits through continued adoption of warm mix asphalt products (E13).
• *Financials:* The company completed the sale of the North Charleston crude tall oil refinery and the majority of the industrial specialties product line on January 1, 2026, as part of a simplification strategy (E16).

Strategic Simplification: Management is actively pursuing a "New Ingevity" strategy. This includes the exploration of strategic alternatives for the Advanced Polymer Technologies (APT) segment and the completion of the road markings divestiture by the end of 2026 (E8, E17). The sale process for APT is reported as progressing well with strong engagement (E8).

Guidance & Capital Allocation:

• 2026 Outlook: Management expects 2026 adjusted EPS to be in the range of $4.70 to $5.20, with net sales between $1.05 billion and $1.15 billion, and adjusted EBITDA between $370 million and $395 million (E1, E2, E9, E10).
• Free Cash Flow: Projected to be $215 million to $245 million (E3).
• Capital Expenditures: Projected 2026 capex is $40–60 million (E15).
• Share Repurchases: The company plans to use free cash flow to continue buying back shares, in line with a prior guidance of $300 million of share repurchases through 2027 (E4).

Legal Context: On February 11, 2026, the U.S. Federal Circuit Court of Appeals ruled against Ingevity on an appeal. Management has decided not to pursue further appeals and expects payment of the judgment, plus post-judgment interest, to be made in the second quarter of 2026 (E21). This liability is now a known, quantified event expected to be settled in the current quarter.

4. Archetype and Conviction

Archetype: Growth Leader Rationale: The name fits the "Growth Leader" archetype due to the combination of double-digit EPS growth expectations (implied by the $4.70–$5.20 range relative to prior years), strong free cash flow generation, and a strategic pivot toward higher-margin, higher-value applications (hybrid vehicle carbon solutions, warm mix asphalt). The business model is shifting from a diversified chemical conglomerate to a streamlined, high-margin specialty materials provider.

Conviction Stack:

• Thesis Strength: Moderate. While there is no external macro thesis, the internal strategic thesis (simplification + hybrid shift) is robust and supported by management guidance.
• Evidence Quality: High. The evidence base is comprehensive, covering earnings transcripts, SEC filings, and financial spine data, all dated prior to or on the event date.
• Structural Quality: Strong. The ATR at breakout (2.9%) and current ATR (3.0%) indicate a "productive" volatility environment, suggesting the move is supported by genuine buying interest rather than erratic speculation. The setup is confirmed, not forming.
• Rerating Potential: Moderate to High. The market is pricing in the successful execution of the simplification strategy (APT sale, road markings exit) and the margin expansion from the hybrid mix shift.

Valuation Context: The financial spine indicates a forward consensus EPS (FY1) of $4.93 and FY2 of $5.76. With the current price at $73.41, the stock trades at approximately 14.9x FY1 consensus, which is reasonable given the projected growth and cash flow generation.

5. Invalidations, Strengtheners, and Gaps

Invalidation Triggers:

• Fundamental: A significant miss on the 2026 EPS guidance (below $4.70) or a failure to close the APT sale process by the end of 2026.
• Legal: Unexpected delays or increases in the judgment payment beyond the Q2 2026 expectation.

Strengtheners:

• Technical: A sustained move above $75–$80, confirming the next leg of the breakout.
• Fundamental: Confirmation of the APT sale at a premium valuation or an acceleration in hybrid vehicle adoption driving further mix shifts.
• Capital Allocation: An acceleration of share buybacks beyond the $300 million guidance.

Gaps in Evidence:

• APT Valuation: While the sale process is "progressing well," the specific valuation or terms of the APT sale are not yet disclosed in the provided evidence.
• Post-Judgment Impact: The exact dollar amount of the judgment and interest is not quantified in the provided text, only the timing of payment.
• 2027 Guidance: The evidence provides 2026 guidance and 2027 buyback guidance, but no specific 2027 earnings or sales guidance is available in the source data.

PRIVATE ANALYST CALL Judgment: Buy Confidence: high Key risks: Legal judgment payment timing or amount; failure to close APT sale by year-end; decline in hybrid vehicle adoption rates. Sizing hint: Standard position sizing for a confirmed breakout with productive ATR; no need to reduce size due to extension as buffer to stop is ample. Expected path: Management executes simplification strategy, APT sale closes, and hybrid mix shift continues to drive margin expansion, supporting the current valuation multiple. Expected horizon: 6 to 12 months for the strategic simplification to fully reflect in earnings. Failure mode to watch: A daily close below $58.87, which would invalidate the structural setup.